Mechanistically, it was revealed by Mao et al. [16] that CBX2 could activate the Hippo pathway via the downregulation of the Yes-associated protein (YAP) expression, thus regulating the proliferation, apoptosis and DNA repair of hepatocellular carcinoma cells. This evidence concerns the gene CBX2 and hepatocellular carcinoma.